Eli Lilly’s Dermira accuses Perrigo of infringing patents

Pharmaceutical company Eli Lilly’s subsidiary Dermira has accused generic drugmaker Perrigo of infringing eight patents for Qbrexza, a prescription-only cloth towelette approved to treat hyperhidrosis, a condition that causes excessive underarm sweating.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

AstraZeneca and Eli Lilly’s Alzheimer’s treatment to be fast tracked

23 August 2016 AstraZeneca and Eli Lilly have received US Food and Drug Administration fast track designation for the development of a treatment for Alzheimer’s.

Americas

Canada slams Eli Lilly’s patent practices in lawsuit response

16 February 2015 The Canadian government has given a scathing assessment of Eli Lilly’s patenting practices in its formal response to the pharmaceutical company’s CAD $500 million lawsuit against it.

More on this story

Americas

AstraZeneca and Eli Lilly’s Alzheimer’s treatment to be fast tracked

23 August 2016 AstraZeneca and Eli Lilly have received US Food and Drug Administration fast track designation for the development of a treatment for Alzheimer’s.

Americas

Canada slams Eli Lilly’s patent practices in lawsuit response

More on this story

Americas

AstraZeneca and Eli Lilly’s Alzheimer’s treatment to be fast tracked

23 August 2016 AstraZeneca and Eli Lilly have received US Food and Drug Administration fast track designation for the development of a treatment for Alzheimer’s.

Americas

Canada slams Eli Lilly’s patent practices in lawsuit response